Recent Updates
Recently added Catalysts
PRGO Positive Sentiment Score: 70/100

Perrigo to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026

Key Takeaway: Perrigo Company plc announced it will release its fourth quarter and fiscal year 2025 financial results on February 26, 2026. The company will host a conference call at 8:30 A.M. (EST) to discuss these results, which will be accessible via webcast and phone. A replay of the call will be available shortly after the event.

Market Sentiment Analysis

POSITIVE FACTORS

  • Perrigo is set to release its financial results, indicating transparency.
  • The company has a strong history in consumer health products.
  • The earnings call provides an opportunity for investor engagement.

Full Press Release Details

DUBLIN,Feb. 13, 2026/PRNewswire/ -- Perrigo Company plc (NYSE:PRGO), a leading provider of consumer health products,today announced that it plans to issue its fourth quarter and fiscal year 2025 financial results on Thursday, February 26th, 2026, and host a conference call beginning at 8:30 A.M. (EST).
The earnings conference call will be available live via webcast to interested parties in the investor relations section of the Perrigo website athttp://perrigo.investorroom.com/events-webcastsor by phone at 800-836-8184, International 646-357-8785, and reference ID # 52719. A taped replay of the call will be available beginning at approximately 12:00 P.M. (EST) Thursday, February 26, until midnight Thursday, March 5, 2026. To listen to the replay, dial 888-660-6345, International 646-517-4150, and use access code 52719#.

About Perrigo

Perrigo Company plc is a leading pure-play consumer health company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers.
Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, includingOpill®, Mederma®, Compeed®, EllaOne®,andJungle Formula®.
For more information, visitwww.perrigo.com.

Forward-Looking Statements

This press release includes, and the matters discussed in Perrigo's upcoming earnings release will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available athttps://investor.perrigo.com/sec-filings, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2024.

Perrigo Contact

Bradley Joseph, Vice President, Global Investor Relations, (269) 686-3373, E-mail:[email protected]
Nicholas Gallagher, Associate Director, Global Investor Relations, (269) 686-3238, E-mail:[email protected]
SOURCE Perrigo Company plc

Frequently Asked Questions

When will Perrigo release its financial results?

Perrigo will release its financial results on February 26, 2026.

What time is the earnings conference call?

The earnings conference call is scheduled for 8:30 A.M. (EST).

How can I access the earnings call?

The call can be accessed via webcast or by phone at specified numbers.

Will there be a replay of the earnings call?

Yes, a replay will be available from 12:00 P.M. (EST) on February 26 until March 5, 2026.

Last updated: Feb 13, 2026